Get the Stockscreener App
8.43
0.36%
0.03
Adicet Bio Inc stock is traded at $8.43, with a volume of 84,910.
It is up +0.36% in the last 24 hours and up +8.43% over the past month.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
See More
Previous Close:
$8.40
Open:
$8.31
24h Volume:
84,910
Relative Volume:
0.52
Market Cap:
$80.74M
Revenue:
$24.99M
Net Income/Loss:
$-118.64M
P/E Ratio:
-6.4351
EPS:
-1.31
Net Cash Flow:
$-100.25M
1W Performance:
+1.81%
1M Performance:
+8.43%
6M Performance:
-35.46%
1Y Performance:
-44.15%
1-Day Range:
$8.17
$8.53
1-Week Range:
$7.76
$8.55
52-Week Range:
$7.1536
$17.44
Adicet Bio Inc Stock (ACET) Company Profile
Name
Adicet Bio Inc
Sector
Industry
Phone
617-482-2333
Address
131 DARTMOUTH STREET, BOSTON
Compare ACET with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACET
Adicet Bio Inc
|
8.41 | 80.64M | 24.99M | -118.64M | -100.25M | -1.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.01 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.87 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
815.87 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.61 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.31 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-24 | Resumed | Guggenheim | Buy |
| Sep-11-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-27-23 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-01-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-21-22 | Initiated | JP Morgan | Overweight |
| Mar-31-22 | Initiated | SMBC Nikko | Outperform |
| Mar-08-22 | Initiated | Truist | Buy |
| Mar-04-22 | Initiated | Jefferies | Buy |
| May-18-21 | Initiated | BTIG Research | Buy |
| Apr-23-21 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Canaccord Genuity | Buy |
| Apr-08-21 | Initiated | Guggenheim | Buy |
| Nov-04-20 | Initiated | B. Riley Securities | Buy |
| Oct-27-20 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-20 | Initiated | Wedbush | Outperform |
View All
Adicet Bio Inc Stock (ACET) Latest News
HC Wainwright Reduces Earnings Estimates for Adicet Bio - MarketBeat
Bond Watch: Will Franklin Wireless Corp outperform tech stocksEarnings Beat & Real-Time Volume Analysis - baoquankhu1.vn
H.C. Wainwright raises Adicet Bio stock price target to $50 on clinical progress By Investing.com - Investing.com India
H.C. Wainwright raises Adicet Bio stock price target to $50 on clinical progress - Investing.com Canada
HC Wainwright & Co. Raises Price Target for ACET to $50 | ACET S - GuruFocus
Adicet Bio (NASDAQ:ACET) Shares Pass Below 200-Day Moving Average – What’s Next? - Defense World
Bond Watch: Is Mondelez International Inc still a buy after recent gains2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Aug Big Picture: Can Adicet Bio Inc ride the EV waveIndex Update & Verified Swing Trading Watchlist - baoquankhu1.vn
Surprises Report: Is Adicet Bio Inc stock a good pick for beginners2025 Technical Patterns & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Adicet Bio (ACET) Price Target Increased by 1,210.53% to 101.59 - Nasdaq
Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) Target Price at $92.50 - Defense World
Risk Hedge: Will Adicet Bio Inc stock reach Wall Street targetsWeekly Trend Report & Real-Time Market Sentiment Alerts - Bộ Nội Vụ
Movement Recap: What is the earnings history of Adicet Bio IncQuarterly Portfolio Review & Weekly Top Gainers Trade List - baoquankhu1.vn
Adicet Bio, Inc. (NASDAQ:ACET) Sees Large Decline in Short Interest - MarketBeat
Adicet Bio, Inc. (NASDAQ:ACET) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Chart Watch: Will ASBPRE stock continue dividend increasesRate Cut & Low Volatility Stock Recommendations - moha.gov.vn
Adicet Bio price target raised to $9 from $4 at H.C. Wainwright - MSN
How Adicet Bio Inc. stock reacts to Fed rate cutsEarnings Miss & Reliable Price Breakout Signals - Улправда
Will Adicet Bio Inc. stock gain from government policies2025 Fundamental Recap & Low Volatility Stock Recommendations - Улправда
Recap Report: Will Adicet Bio Inc. stock gain from government policies2025 Fundamental Recap & Low Volatility Stock Recommendations - Улправда
Is Adicet Bio Inc. stock attractive for growth ETFs2025 Technical Patterns & Accurate Buy Signal Alerts - Улправда
Will Adicet Bio Inc. stock benefit from automationTrade Entry Report & Verified Momentum Stock Ideas - ulpravda.ru
Enterprise value of Adicet Bio Inc – LS:A41X5V - TradingView — Track All Markets
Adicet Bio (NASDAQ:ACET) Stock Passes Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Adicet Bio (NASDAQ:ACET) Stock Passes Below Two Hundred Day Moving Average – Should You Sell? - Defense World
Press Release Service: Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones - CRISPR Medicine News
Adicet Bio advances prula-cel autoimmune Phase 1 program - TipRanks
Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones - FinancialContent
Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment - Benzinga
Canaccord Genuity lowers Adicet Bio stock price target to $18 from $128 - Investing.com Nigeria
Check out 's stock price (1IJ-FF) in real time - CNBC
Adicet Bio Inc Income Statement – TRADEGATE:1IJ - TradingView — Track All Markets
Net current asset value per share of Adicet Bio Inc – GETTEX:1IJ - TradingView — Track All Markets
Net debt of Adicet Bio Inc – LSX:A41X5V - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of Adicet Bio Inc – GETTEX:1IJ - TradingView — Track All Markets
Operating margin % of Adicet Bio Inc – GETTEX:1IJ - TradingView — Track All Markets
Adicet Bio Inc Financial Statements – TRADEGATE:1IJ - TradingView — Track All Markets
After tax other income/expense of Adicet Bio Inc – TRADEGATE:1IJ - TradingView — Track All Markets
Gross profit of Adicet Bio Inc – GETTEX:1IJ - TradingView — Track All Markets
Quick ratio of Adicet Bio Inc – TRADEGATE:1IJ - TradingView — Track All Markets
Number of employees of Adicet Bio Inc – TRADEGATE:1IJ - TradingView — Track All Markets
Free cash flow per share of Adicet Bio Inc – TRADEGATE:1IJ - TradingView — Track All Markets
Price to cash flow ratio of Adicet Bio Inc – TRADEGATE:1IJ - TradingView — Track All Markets
Cost of goods sold of Adicet Bio Inc – TRADEGATE:1IJ - TradingView — Track All Markets
EBIT of Adicet Bio Inc – GETTEX:1IJ - TradingView — Track All Markets
Cash from operating activities of Adicet Bio Inc – TRADEGATE:1IJ - TradingView — Track All Markets
Working capital per share of Adicet Bio Inc – GETTEX:1IJ - TradingView — Track All Markets
Price to cash flow ratio of Adicet Bio Inc – GETTEX:1IJ - TradingView — Track All Markets
Revenue per share of Adicet Bio Inc – LS:A41X5V - TradingView — Track All Markets
Taxes of Adicet Bio Inc – MUN:1IJ - TradingView — Track All Markets
Adicet Bio Inc Statistics – GETTEX:1IJ - TradingView — Track All Markets
Adicet Bio Inc Stock (ACET) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.27%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):